Member Info for banjomick

Yes if all resolutions are passed, which they should be, then after the EGM next Thursday might bring a production update and with the finances approved news on future expansions.

Result of Annual General Meeting

29 January 2026 - Allergy Therapeutics plc (AIM:AGY), the fully commercial biotechnology company specialising in allergy immunotherapies, announces that all resolutions proposed at the 2026 Annual General Meeting ("AGM") held today were duly passed by shareholders on a show of hands.

Hi Ralph, there is bound to be a pull-back as the SP has gone from 0.4p to 1.5p in a few days, anything else would be very odd indeed!

GRL are in a bit of a speculation situation regarding the SP after the recent rise so now all depends on news after the EGM which is on Thursday, 5 February to see where they are heading, in my opinion.

You could possibly think the massive rise in SP is due to potential future performance due to the backing recently announced but we will have to see over the next few weeks or months what unfolds....

Hi Paul, just back from pub pool practice which finished very early....

I believe GRL will announce more details after the EGM regarding the 'Use of Proceeds' in due time.

They did go on to say ""We are pleased to have conditionally raised £2.0 million, which strengthens the Company's balance sheet and provides funding to accelerate exploration at the Homase Mine while also enabling us to consider additional opportunities beyond our core asset. The support shown through the subscription, together with the conversion of debt and fees into equity, demonstrates continued alignment with shareholders as we advance the Company's growth strategy."" Therefore there will be updates in the following weeks/months I'd assume.....

A reminder from the last RNS and yes I take fully on-board the lack of 'targets' being met over the years but GRL in their current form are a relatively new company going from exploration to producer:

"We are pleased to have conditionally raised £2.0 million, which strengthens the Company's balance sheet and provides funding to accelerate exploration at the Homase Mine while also enabling us to consider additional opportunities beyond our core asset. The support shown through the subscription, together with the conversion of debt and fees into equity, demonstrates continued alignment with shareholders as we advance the Company's growth strategy."

Hi ID, got rained off from gardening work, horrible out there! I know you asked boo but I to would expect an improvement in gold production from the next update for a few reasons:

1. It's the dry season now, therefore no delays from rainfall

2. "A new screening and conveying system was completed and commissioned in December 2025, enabling stacking rates of up to 56,000 tonnes of agglomerated ore per month, providing increased operational flexibility." That's obviously depending on whether it's on-line and working after commissioning!

3. "The mining schedule has been restructured to maximise production during drier operational periods"

4. With the new board now settled in, by the sounds of it overseeing day to day activities, along with lessons learnt and the experience gained over the last two years or so, should make the whole process more efficient yielding greater gold production..........in theory! :-)

Amazing few days with more to come I hope!

Yes, just about breakeven now which is great!

The EGM is on Thursday, 5 February 2026 so GRL will update the market probably on the same day, I would imagine with all resolutions passed. As I said over the road earlier that GRL may take this opportunity or soon after to update the market on gold production and/or more detail on future plans but just a guess on my part!

Was, it's not a case of trusting Emma in my opinion?

GRL are producing gold but obviously not meeting their target figures for last year.

I think what most are missing, whether deliberately or not, is that GRL were/are a very small mining company but they are producing gold from a very gold rich area of Ghana!

My opinion is their current operation is basically keeping the lights on while they 'try' to achieve their long term plan !

The board is now stronger, again in my opinion, and with the recent financial boost the company is looking in a far better state for said future growth!

Exciting times one way or t'other!

Was, I take it you will be buying in tomorrow then? :-)

Hi Fr, that is not the case at all! The plant is capble of producing more than 3000oz/p but for various reasons their production targets were not achieved.

Over the last couple of years or so GRL have been adding to and improving the plant/machinery hence why the ISC is on the higher side! The AISC cost will obviously stay round the current level this year as they make more improvements.

As Emma said, GRL re very small gold producer t the present time, I'd go as far to say they re just out of the development stage and hence why production targets were not met!

It's going to be very interesting to see the progress over this year especially with the new directors in place and the £2 million raised few days go.

I would imagine the next news will be the results of the EGM on 5th February 2026, so not long to wit!

Wow, LSE doesn't like saving 'A's ' when I post!

Hi Fr, tht is not the cse t ll! The plnt is cpble of producing more thn 3000oz/p but for vrious resons their production trgets were not chieved.

Over the lst couple of yers or so GRL hve been dding to nd improving the plnt/mchinery hence why the ISC is on the higher side! The ISC cost will obviously sty round the current level this yer s they mke more improvements.

s Emm sid, GRL re very smll gold producer t the present time, I'd go s fr to sy they re just out of the development stge nd hence why production trgets were not met!

It's going to be very interesting to see the progress over this yer especilly with the new directors in plce nd the £2 million rised few dys go.

I would imgine the next news will be the results of the EGM on 5th Februry 2026 so not long to wit!

GG, very exciting times for GRL over the next year or two, you have to be in to win! :-)

Sorry, still in pub after a wet day hedge cutting and just watched interview and hour ago

Trading update for the six months ended 31 December 2025

Strong H1 with recovery of the underlying product portfolio in Germany

Grassmuno®: First new launch in the German subcutaneous immunotherapy market in the last 20 years

- Momentum building with H1 revenues expected to be £36.3 million (H1 2025: £34.0 million) representing 7% growth on a reported basis in spite of a significant phase out of German TAV products

- Commercialisation of Grassmuno® has commenced in the second half of the financial year following the marketing authorisation approval from the Germany regulatory authority in December 2025

- Cash position of £10.1 million at 31 December 2025 (30 June 2025: £12.8 million) following repayment of all outstanding shareholder loans

- The board remains confident in delivering revenue growth in year to 30 June 2026

19 January 2026: Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapies, today announces its trading update for the six months ended 31 December 2025.

The Group expects revenue for the six months ended 31 December 2025 to be £36.3 million (2024: £34.0 million), representing growth of 7 percent on a reported basis, or 3 percent on a constant currency basis*. This performance is positive given the ongoing transition away from unregistered products under Germany's TAV programme and reflects strong growth in the Group's existing German registered product portfolio.

During the period, the Group received marketing authorisation in Germany for Grassmuno®, the first subcutaneous grass pollen immunotherapy approved under the TAV programme. Commercialisation commenced in January 2026 and sales momentum is expected to accelerate further in the second half of the financial year. Overall Group sales for the full year ending 30 June 2026 are expected to exceed those achieved in the year ended 30 June 2025.

The Group's cash balance as at 31 December 2025 was £10.1 million (30 June 2025: £12.8 million). As previously announced, during the period the Company received exercise notices from the Shareholder Lenders in respect of their warrants, generating aggregate proceeds of £55 million. These proceeds were applied to repay all outstanding financial indebtedness owed to the Shareholder Lenders, significantly reducing the Group's level of debt and strengthening the balance sheet.

In addition, the Shareholder Lenders agreed to provide a new £50 million unsecured loan facility although no amounts had been drawn as at 31 December 2025.

Together with the previously announced £20 million uncommitted Hayfin facility, the Group has access to total uncommitted funding of £70 million, while it continues to explore a potential dual primary listing on the Hong Kong Stock Exchange.

The Company intends to announce its Interim Results in March 2026.

https://allergytherapeutics2024eutfm.q4web.com/news/news-detai

SHOP APOTHEKE which I believe is a German/Dutch online pharmacy which covers other European countries too has the Grassmuno® (Grass MATA MPL) product penciled in for sale:

hxxps://www.shop-apotheke.com/arzneimittel/20186171/grassmuno-injektionssuspension.htm

It looks like Shop Apotheke was bought out or was already owned by Redcare Pharmacy which is a huge online, including TV sales channels, across Europe:

In 2024, e-prescriptions became the nationwide standard in Germany for all publicly insured patients. To access the digitalised Rx market, Redcare secured approval from the Ministry of Health and the gematik to launch a new and fully digital patient journey via CardLink. With this customer-centric solution, Redcare tripled its Rx market share within the year, reinforcing the pharmacy’s market leadership in Germany to include prescription medications.

Redcare pharmacy also became the market leader in Italy, where the online share of the pharmacy sector is approaching EUR 1 billion in revenue. With this achievement, Redcare is now market leader in five of its seven countries.

Following the success of its marketplaces in Germany and Austria, Redcare also launched marketplaces in Belgium and Italy, significantly expanding the assortments available to its customers in these countries.

hxxps://www.redcare-pharmacy.com/newsroom/press-releases/fy2024

hxxps://www.redcare-pharmacy.com/de/about-us

Boo, from the pictures there are only soil roads for transporting the mined material to the stockpile and on to the crusher so you can imagine how bad they will get in a heavy rainy season! The conveyor belt system is not covered and the ore will already be soaked as they add the lime/cement which will have a detrimental affect on the chemical reaction to separate the gold from the ore. The rest of the process will also be affected by the moisture content of the agglomeration ore!

As you alluded to before GRL are a very small company with little money for the next step up but that's not to say 2026 will be better than forecast!

The last update was more detailed than previous communications albeit not as positive as previous updates but I'd rather they told it as it was along with projections for 2026!

Why do you say the CEO disappeared from site?

Hi boo, your post "What we have here is a young, and ibdare say inexperienced / poorly funded start up miner trying to muddle through / manage cashflow." is spot on, in my opinion.

Regarding the "unusually heavy rainy season" and the affect it has on the whole mining process, if you look at the company pictures from links below, you might have to cut and past them, they show quite clearly the affect a heavy rainy season would have:

https://www.goldstoneresources.com/wp-content/uploads/2024/10/Homase-Mine-and-Heap-Leach-September-2024.pdf

https://otp.investis.com/clients/uk/goldstone_resources_ltd/rns/regulatory-story.aspx?cid=1561&newsid=1921666

HC, well done you lasted 6 days! :-)

HC, I take it you won't be buying back in then? :-)